Effective September 30, 2026, the Company suspended and terminated the prospectus supplement (the "ATM Prospectus Supplement") related to the Company’s Series A common stock, par value $0.0001 per share (the "Common Stock"), issuable pursuant to the terms of a Sales Agreement, dated August 14, 2025, by and between the Company and Leerink Partners LLC (the "Sales Agreement"). As a result, the Company will not make any sales of the Company’s Common Stock pursuant to the Sales Agreement unless and until a new prospectus, prospectus supplement or a new registration statement is filed. Other than the termination of the ATM Prospectus Supplement, the Sales Agreement remains in full force and effect.